In this presentation, we welcome Unicycive Therapeutics, Nasdaq ticker symbol UNCY. And with us today is their Chairman and CEO, Shalabh Gupta. Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases.

This Fireside Chat was recorded during the Lytham Partners Spring 2024 Investor Conference.